Estrella Immunopharma, Inc.
ESLA · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,848 | -$7,312 | -$996 | -$1,685 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $29 | $0 |
| Stock-Based Comp. | $0 | $1,195 | $0 | $130 |
| Change in WC | $776 | -$9,951 | $577 | $113 |
| Other Non-Cash | $509 | $0 | -$654 | -$1 |
| Operating Cash Flow | -$7,640 | -$16,068 | -$1,044 | -$1,442 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$45,186 |
| Inv. Sales/Matur. | $0 | $0 | $36,170 | $0 |
| Other Inv. Act. | $0 | $4,961 | $0 | $0 |
| Investing Cash Flow | $0 | $4,961 | $36,170 | -$45,186 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10,000 | $0 | $499 | $0 |
| Stock Issued | $79 | $0 | $0 | $46,892 |
| Stock Repurch. | -$569 | -$354 | -$36,113 | -$25 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,579 | $13,148 | $50 | $5,530 |
| Financing Cash Flow | -$489 | $12,794 | -$35,564 | $5,530 |
| Forex Effect | $0 | $0 | $0 | $45,186 |
| Net Chg. in Cash | -$8,129 | $1,686 | -$438 | $4,088 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,046 | $2,479 | $479 | $0 |
| End Cash | $917 | $4,165 | $41 | $4,088 |
| Free Cash Flow | -$7,640 | -$16,068 | -$1,044 | -$1,442 |